In a study of 179 people with MS, narrower blood vessels in the back of the eye were linked to greater disability, but an eye scan alone cannot show what caused it.
Researchers took pictures of the tiny blood vessels in the back of participants’ eyes and measured their width. People with narrower vessels were more likely to have higher disability scores, which rate how much MS affects movement and daily activities. A small decrease in vessel width was linked to about 24% higher odds of being in the study’s higher-disability group. Age, high blood pressure, body weight, and smoking were also linked to vessel width. When researchers accounted for thinning of nerve cells in the eye, the vessel link was no longer clear, though using both eye measurements helped identify the higher-disability group better than either measurement alone.
People with MS may find this useful because the eyes could offer another window into changes linked with disability. Think of an eye scan as one piece of a puzzle, not a replacement for talking with your care team about symptoms and daily challenges. If you already have eye scans, you can ask your clinician what they show and whether the results matter for your care. The links with smoking and heart health also make it worth discussing blood pressure, weight, and smoking with your healthcare provider. Caregivers can help by keeping track of changes in daily activities and bringing questions to appointments.
This study looked at people at one point in time, so it cannot show whether narrower eye vessels cause disability or predict future changes. The vessel link became unclear after researchers accounted for thinning of eye nerve cells, making it hard to tell what the vessel measurement adds on its own. Eye vessel measurements are not a stand-alone test for MS disability, so do not change treatment based on an eye image without speaking to your care team.
AI-generated summary — for informational purposes only, not medical advice
11/1/2026
A study of children with MS found blood changes linked to immune activity and a common virus. Learn
Read More9/28/2026
Learn how MRI scans may help tell MOGAD from MS, why scan timing matters, and what to ask your care
Read More9/28/2026
A study of 17 people links worsening weakness to MS-related damage in the brain. Learn what the find
Read More9/28/2026
A small study suggests an early blood test may help predict nerve damage and trouble seeing faint le
Read More9/27/2026
A study links a blood marker that looks older than your age with greater MS disability. Learn what i
Read More9/26/2026
Does MS run in your family? A Swedish study found family history did not predict faster disability o
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Multiple sclerosis (Houndmills, Basingstoke, England) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.